| News

TargImmune raises nearly 18 million Swiss francs

20.07.2021

The Basel-based biotechnology firm TargImmune has raised 17.7 million Swiss francs as part of a financing round. It now intends to transfer its lead candidate to clinical development. The company develops immunotherapies for the targeted destruction of tumors.

TargImmune Therapeutics develops targeted immunotherapies that fight the tumor itself, alert the immune system and destroy neighboring tumor cells. The Basel-based company now intends to transfer its lead product candidate Tar001 to clinical development and can call upon proceeds raised from a financing round for this purpose, further details of which can be found in an article published by startupticker.ch. TargImmune raised a total of 17.7 million Swiss francs in the aforementioned financing round.

Based at the Technologiepark Basel, TargImmune is developing its drug using the company’s proprietary RNA platform. Clinical development is expected to begin in the second quarter of 2022. TargImmune also plans to file an application with the U.S. Food and Drug Administration with the aim of securing Investigational New Drug status.

However, CEO Esteban Pombo-Villar is set to leave his post and will in future work as Head of Technology for the Basel-based company, which was founded back in 2016. On August 16, 2021, Peter Braun will then take over management responsibility. He has 25 years of professional experience. Most recently, he worked for the Norwegian company Nordic Nanovector.

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

EsoCap impresses investors
Basel Area Business & Innovation, Innovation, Invest

EsoCap impresses investors

EsoCap, a biotech company based in Basel, has concluded a successful funding round. The funds from new and existing investors...

Read More
Plug and Play settles in the Basel Area
Basel Area Business & Innovation, Innovation, Invest

Plug and Play settles in the Basel Area

Plug and Play is coming to the canton of Basel-Landschaft. The first founding partner of the innovation promoter from Silicon...

Read More
Bachem builds its largest production building
Basel Area Business & Innovation, Innovation, Invest

Bachem builds its largest production building

Bachem has laid the foundation stone for its largest production building to date. The company specializing in the manufacture of...

Read More
Bottneuro advancing personalized Alzheimer’s therapy
Basel Area Business & Innovation, Innovation, Invest

Bottneuro advancing personalized Alzheimer’s therapy

Basel-based startup Bottneuro is working on the development of personalized therapies to treat Alzheimer’s disease in which certain areas of...

Read More
Straumann plans to build innovation center in the Basel Area
Basel Area Business & Innovation, Innovation, Invest

Straumann plans to build innovation center in the Basel Area

The Basel-based dental specialist Straumann is planning to construct a new technology and innovation center in Arlesheim in the canton...

Read More
Ontotext opens new office in the Basel Area
Basel Area Business & Innovation, Innovation, Invest, Switzerland Innovation Park

Ontotext opens new office in the Basel Area

Ontotext, a company based in New York City and the Bulgarian capital of Sofia, has opened a new location at...

Read More
1 2 3 19

Do you have a question? We'd like to hear from you.